• Babu R Vels Institute of Science Technology and Advanced Studies, Vels University, Pallavaram, Chennai, Tamil Nadu, India
  • Satheeshkumar S Adhiparasakthi College of Pharmacy, Melmaruvathur, Tamil Nadu, India.
  • Shanmugasundaram P Vels Institute of Science Technology and Advanced Studies, Vels University, Pallavaram, Chennai, Tamil Nadu, India


Objective: The objective of the present study was to develop sustained release matrix tablets of levosulpiride by using natural polymers.

Method: The tablets were prepared with different ratios of Chitosan, Xanthan gum and Guar gum by wet granulation technique. The solubility study of the levosulpiride was conducted to select a suitable dissolution media for in vitro drug release studies.

Results: Fourier transform infrared (FTIR) study revealed no considerable changes in IR peak of levosulpiride and hence no interaction between drug and the excipients. DSC thermograms showed that no drug interaction occurred during the manufacturing process. In vitro dissolution study was carried out for all the formulation and the results compared with marketed sustained release tablet. The drug release from matrix tablets was found to decrease with increase in polymer ratio of Chitosan, Xanthan gum and Guar gum.

Conclusion: Formulation LF3 exhibited almost similar drug release profile in dissolution media as that of marketed tablets. From the results of dissolution data fitted to various drug release kinetic equations, it was observed that highest correlation was found for First order, Higuchi’s and Korsmeyer equation, which indicate that the drug release occurred via diffusion mechanism.  



Keywords: Levosulpiride, sustained release tablets, natural polymers, in vitro drug release studies


1. Ansel HC, Allen LV, Popovich NG. Pharmaceutical Dosage Forms and Drug Delivery System. 4th ed. New Delhi: Lippincott Williams and Wilkins; 2009. p. 227-74.
2. Aulton ME. Pharmaceutics: The Design and Manufacture of Medicine. 3rd ed. New York: Churchill Livingstone; 2007. p. 355-9, 483-98.
3. O’Niel MJ. The Merck Index. 12th ed. New Jersey: Merck & Co.; 1996. p. 9163.
4. Hardman JG, Limbird LE, editors. Goodman and Gilman’s the Pharmacological Basis of Therapeutics. 10th ed. New York: McGraw Hill; 2001. p. 1349-59.
5. Reynolds JE. Martindale - The Extra Pharmacopaeia. 13th ed. London: The Pharmaceutical Press; 1993. p. 615.
6. Tanwar SS. Formulation and evaluation of sustained release matrix tablets of levosulpiride. Res J Pharm Biol Chem Sci 2013;4(2):1326-35.
7. Anonymous. Indian Pharmacopoeia. Vol. I, II and III. Ghaziabad, India: Government of India Ministry of Health and Family Welfare, The Indian Pharmacopoeia Commission; 2007. p. 142-83, 1276-85.
8. Carstensen JT, Rhodes CT. Drug Stability Principles and Practices. 3rd ed. New York: Marcel Dekker, Inc.; 2008. p. 415-81.
9. Nazir I, Abbas J, Asad M, Bashir S, Rasul A, Ahmad N, et al. Formulation and in vitro evaluation of orodispersible tablet of levosulpiride. J Pharm Cosmet Sci 2013;1(4):53-6.
10. Brahmbhatt DD, Patel MB, Patel JC. Development and validation for estimation of levosulpiride by area under curve and difference spectrophotometric method. Int J ChemTech Res 2012;4(3):945-50.
11. Maheswaran A, Padmavathy J, Nandhini V, Saravanan D, Angel P. Formulation and evaluation of floating oral in situ gel of diltiazam hydrochloride. Int J Appl Pharm 2017;9(1):50-3.
12. Husen PM. Design and evaluation of controlled release matrix tablets of metoclopramide hydrochloride using hydrophilic polymers. Int J Curr Pharm Res 2012;4(3):64-9.
13. Kumar PS, Arivuchelvan A, Jagadeeswaran A, Subramanian N, Kumar CS. Formulation, optimization and evaluation of enrofloxacin solid lipid nanoparticles for sustained oral delivery. Asian J Pharm Clin
Res 2015;8(1):231-6.
14. International Conference on Harmonization (ICH). Harmonized Tripartite Guideline for Stability Testing of New Drugs Substances and Products Q1A (R2). Rockville, MD: United States Pharmacopoeial Convention, Inc.; 2003. p. 6.
15. Albadry AA, Wedad K Ali, Fouad A Alsaady. Formulation and evaluation of prochloperazinemaleate sustained release floating tablets. Int J Pharm Pharm Sci 2017;9:89-98.
16. Thorat R, Patil P, Aage R, Puranik P, Virajselve. Formulation development and evaluation of venlafaxine HCl sustained release matrix tablets. Int J Pharm Pharm Sci 2013;5:757-65.
577 Views | 1333 Downloads
How to Cite
S, S., B. R, S. S, and S. P. “FORMULATION AND EVALUATION OF SUSTAINED RELEASE MATRIX TABLETS OF LEVOSULPIRIDE BY USING NATURAL POLYMER”. Asian Journal of Pharmaceutical and Clinical Research, Vol. 10, no. 5, May 2017, pp. 285-92, doi:10.22159/ajpcr.2017.v10i5.17475.
Original Article(s)